Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James E Neffendorf

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Acta Ophthalmologica|September 1, 2017
Intravitreal gas for symptomatic vitreomacular adhesion: a synthesis of the literatureJames E Neffendorf, Andrew R H Simpson, David H W Steel, et al.
The British Journal of Ophthalmology|July 6, 2026
Safe use of fluorinated gases in vitreoretinal surgery: learning from patient safety incidents with expert panel recommendations from the British and Eire Association of Vitreoretinal Surgeons (BEAVRS)Fernando J Huelin, Peter Kiraly, George Moussa, et al.
American Journal of Ophthalmology|June 15, 2019
Improved Diagnosis of Retinal Laser Injuries Using Near-Infrared AutofluorescenceSamantha R De Silva, James E Neffendorf, Johannes Birtel, et al.
Aesthetic Surgery Journal|January 6, 2026
Consensus Guidelines for the Management of Tissue Filler-induced Vision Loss in the United KingdomStafford Sansome, Mike Clague, Cormac Convery, et al.
Ophthalmology and Therapy|November 20, 2021
Confidence of UK Ophthalmology Registrars in Managing Posterior Capsular Rupture: Results from a National Trainee SurveyAndrew J Swampillai, Victoria A Nowak, Laura Maubon, et al.
Trials|November 25, 2016
StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): study protocol for a randomised controlled clinical trialJames E Neffendorf, Riti Desai, Yanzhong Wang, et al.
JAMA Ophthalmology|July 10, 2020
Evaluation of Month-24 Efficacy and Safety of Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration: The MERLOT Randomized Clinical TrialTimothy L Jackson, Cristina Soare, Caroline Petrarca, et al.
Ophthalmology|April 18, 2016
Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration (MERLOT): A Phase 3 Randomized Controlled TrialTimothy L Jackson, Riti Desai, Andrew Simpson, et al.
The British Journal of Ophthalmology|February 26, 2022
Epimacular brachytherapy for previously treated neovascular age-related macular degeneration: month 36 results of the MERLOT randomised controlled trialTimothy L Jackson, Cristina Soare, Caroline Petrarca, et al.
Lancet (London, England)|June 14, 2024
Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trialTimothy L Jackson, Riti Desai, Hatem A Wafa, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Acta Ophthalmologica|September 1, 2017
Intravitreal gas for symptomatic vitreomacular adhesion: a synthesis of the literatureJames E Neffendorf, Andrew R H Simpson, David H W Steel, et al.
The British Journal of Ophthalmology|July 6, 2026
Safe use of fluorinated gases in vitreoretinal surgery: learning from patient safety incidents with expert panel recommendations from the British and Eire Association of Vitreoretinal Surgeons (BEAVRS)Fernando J Huelin, Peter Kiraly, George Moussa, et al.
American Journal of Ophthalmology|June 15, 2019
Improved Diagnosis of Retinal Laser Injuries Using Near-Infrared AutofluorescenceSamantha R De Silva, James E Neffendorf, Johannes Birtel, et al.
Aesthetic Surgery Journal|January 6, 2026
Consensus Guidelines for the Management of Tissue Filler-induced Vision Loss in the United KingdomStafford Sansome, Mike Clague, Cormac Convery, et al.
Ophthalmology and Therapy|November 20, 2021
Confidence of UK Ophthalmology Registrars in Managing Posterior Capsular Rupture: Results from a National Trainee SurveyAndrew J Swampillai, Victoria A Nowak, Laura Maubon, et al.
Trials|November 25, 2016
StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): study protocol for a randomised controlled clinical trialJames E Neffendorf, Riti Desai, Yanzhong Wang, et al.
JAMA Ophthalmology|July 10, 2020
Evaluation of Month-24 Efficacy and Safety of Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration: The MERLOT Randomized Clinical TrialTimothy L Jackson, Cristina Soare, Caroline Petrarca, et al.
Ophthalmology|April 18, 2016
Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration (MERLOT): A Phase 3 Randomized Controlled TrialTimothy L Jackson, Riti Desai, Andrew Simpson, et al.
The British Journal of Ophthalmology|February 26, 2022
Epimacular brachytherapy for previously treated neovascular age-related macular degeneration: month 36 results of the MERLOT randomised controlled trialTimothy L Jackson, Cristina Soare, Caroline Petrarca, et al.
Lancet (London, England)|June 14, 2024
Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trialTimothy L Jackson, Riti Desai, Hatem A Wafa, et al.
Pageof 4